Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Short Term Treatment With Clarithromycin Resulting in Colchicine-Induced Rhabdomyolysis
Journal of Clinical Rheumatology (JCR), 09/09/09
McKinnell J et al. – A case of colchicine–induced rhabdomyolysis is reported. A review of medications that are metabolized via the cytochrome 3A4 and A–SLAVED–LIVER (Amiodarone, Simvastatin, Lovastatin, Atorvastatin, Verapamil, Erythromycin, Diltiazem, cLarithromycin, Itraconazole, Voriconazole, colchicinE, Ritonavir) pneumonic was established.
Related Articles
Clarithromycin Resistance and Efficacy of Clarithromycin-Containing Triple Eradication Therapy for Helicobacter pylori Infection in Type 2 Diabetes Mellitus Patients
Southern Medical Journal, 11/09/09
Relevance Score: 87%
Clarithromycin–Amoxycillin-Containing Triple Therapy: A Valid Empirical First-Line Treatment for Helicobacter pylori Eradication in Hong Kong
Helicobacter, 11/09/09
Relevance Score: 87%
Physiologically-Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin
Drug Metabolism and Disposition, 11/06/09
Relevance Score: 87%
Analysis of Clarithromycin Resistance and CagA Status in Helicobacter pylori Using Feces from Children in Thailand
Journal of Clinical Microbiology, 10/08/09
Relevance Score: 87%
Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine
European Journal of Pain, 11/10/09
Relevance Score: 85%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid
Osteoporosis International, 11/24/09
Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: A prospective study
Osteoporosis International, 11/24/09
Treatment of osteoporosis: Recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
Osteoporosis International, 11/24/09
Today in Gout and Hyperuricemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Prescription and comorbidity screening following consultation for acute gout in primary care
Rheumatology, 11/23/09
Osteoclasts are important for bone angiogenesis
Blood, 11/19/09
Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease
PLoS ONE - Cardiovascular Disorders, 11/10/09
Sponsor
Article Search
Sponsor


See Latest Articles


